T. Rowe Price Investment Management’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$26M Sell
248,726
-18,271
-7% -$1.91M 0.02% 471
2025
Q1
$31.1M Buy
+266,997
New +$31.1M 0.02% 468